Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now

J Diabetes Sci Technol. 2020 Jul;14(4):752-753. doi: 10.1177/1932296820930289. Epub 2020 May 22.

Author

Julia K Mader¹

Affiliation

¹ Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria.

No abstract available

Keywords: COVID-19; diabetes management; telemedicine.

MeSH terms

Austria / epidemiology
Blood Glucose Self-Monitoring / methods
COVID-19
Chronic Disease
Coronavirus Infections / epidemiology*
Diabetes Complications / prevention & control
Diabetes Complications / therapy
Diabetes Mellitus / therapy*
Diabetic Foot / prevention & control
Diabetic Foot / therapy
Glucagon-Like Peptide-1 Receptor / antagonists & inhibitors
Humans
Insurance, Health
Outpatients
PCSK9 Inhibitors
Pandemics
Pneumonia, Viral / epidemiology*
Reimbursement Mechanisms
Telemedicine / economics
Telemedicine / methods*
Treatment Outcome

Substances

GLP1R protein, human
Glucagon-Like Peptide-1 Receptor
PCSK9 Inhibitors
PCSK9 protein, human